E.A. GAFAROVA

Kazan State Medical Academy, 36 Butlerov St., Kazan, Russian Federation, 420012 

Gafarova E.A. ― Cand. Med. Sc,, Associate Professor of the Department of Obstetrics and Gynecology №1, tel. +7-917-287-44-28, e-mail: lenochkae@list.ru 

Current data show the dependence of the degree of metabolic and hormonal disturbances on the phenotype of polycystic ovary syndrome (PCOS). A study of vitamin D blood level, hormonal (FSH, LH, total testosterone, androstenedione, AMG) background, parameters of carbohydrate metabolism and constitutional features was carried out in 65 women with polycystic ovary syndrome. The basic hormonal and metabolic characteristics of patients with different PCOS phenotypes and their relationship with the vitamin D level are shown.

Key words: PCOS phenotypes, vitamin D, 25 (OH) D3, hyperandrogenism, antimüllerian hormone (AMH), insulin-resistance, hyperinsulinemia, abdominal obesity.

 

 

REFERENCES

1. Uvarova E.V., Khashchenko E.P. Polycystic ovary syndrome from the standpoint of pathogenesis. Reproduktivnoe zdorov’e detey i podrostkov, 2011, no.4, pp. 10-18 (in Russ.).

2. Madyanov V.I., Madyanova T.S. Phenotypic variants emerging polycystic ovary syndrome in adolescent girls. Zdravookhranenie Chuvashii, 2015, no. 2, pp. 30-36 (in Russ.).

3. Shepel’kevich A.D., Barsukov A.N., Mantachik M.V. Current approaches to diagnosis and treatment of polycystic ovary syndrome. Lechebnoe delo, 2014, no. 2, pp. 21-26 (in Russ.).

4. Dedov I.I., Mel’nichenko G.A., Chebotnikova T.V. et al. Prevalence and clinical picture of polycystic ovary syndrome in the population of Moscow. Problemy endokrinologii, 2010, no. 4, pp. 3-8 (in Russ.).

5. Moran C., Arriaga M., Rodriguez G. et al. Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome. Int. J. Endocrinol, 2012, vol. 2012, pp. 1-16.

6. Chernukha G.E., Blinova I.V., Kuprashvili M.I. Endocrine and metabolic characteristics of patients with different phenotypes of polycystic ovary syndrome. Akusherstvo i ginekologiya, 2011, no. 2, pp. 12-19 (in Russ.).

7. Romualdi D., Di Florio C., Tagliaferri V. et al. The Role of Anti-Müllerian Hormone in the characterization of the different polycystic ovary syndrome phenotypes. Reprod. Sci, 2015, no. 29. pii: 1933719115611751.

8. Jamil A.S., Alalaf S.K., Al-Tawil N.G., Al-Shawaf T. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria. Arch. Gynecol. Obstet., 2016, vol. 293, no. 2, rr. 447-456.

9. Bogdanova P.S. at al. Anti-Müllerian hormone (AMH) in adolescent girls with hyperandrogenism. Problemy endokrinologii, 2012, no. 1, pp. 9-16 (in Russ.).

10. Boyarskiy K.Yu., Gaydukov S.N., Mashkova E.A. Role antimyullerova hormone in normal and various gynecological diseases. Zhurnal akusherstva i zhenskikh bolezney, 2009, vol. LVIII, iss. 3, pp. 75-85 (in Russ.).

11. Irani M., Seifer D., Minkoff H., Merhi Z. Vitamin D normalizes abnormally elevated serum antimülleria. Obstet. Gynecol, 2014, no. 123, rr. 189-194.

12. Korovina N.A., Zakharova I.N., Cheburkin A.V. A new look at vitamins D. Russkiy meditsinskiy zhurnal, 2000, no.1, pp. 32-36 (in Russ.).

13. Anagnostis P., Karras S., Goulis D.G. Vitamin D in human reproduction: a narrative review. Int. J. Clin. Pract, 2013, vol. 67, no. 3, rr. 225-235.

14. Brzozowska M., Karowicz-Bilińska A. The role of vitamin D deficiency in the etiology of polycystic ovary syndrome disorders. Ginekol. Pol, 2013, no. 84 (6), rr. 456-460.

15. Grzechocinska B., Dabrowski F.A., Cyganek A. et al. The role of vitamin D in impaired fertility treatment. Neuro Endocrinol. Lett, 2013, vol. 34, no. 8, rr. 756-762.

16. Lagunova Z., Porojnicu A., Lindberg F. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer. Res., 2009, vol. 9, no. 9, rr. 3713-3720.

17. Naimi Z.M.S., Kalinina E.A., Donnikov A.E. et al. The role of vitamin D in the outcomes of assisted reproductive technology programs. Akusherstvo i ginekologiya, 2015, no. 11, pp. 5-9. (in Russ.).

18. Raja-Khan N., Shah J., Stetter C.M. et al. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial. Fertil. Steril, 2014, no. 14.